SCHEMBL22356643

SCHEMBL22356643

O=C(Cc1ccccc1-c1cc(NC(=O)C(F)(F)F)n[nH]1)OCc1ccccc1

nearest known ligand 0.45

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
NPY5R Q15761 3/20 0.41
L3MBTL1 Q9Y468 2/20 0.40
ALDH1A1 P00352 2/20 0.40
MAPK1 P28482 1/20 0.40
ENPP2 Q13822 1/20 0.39
KDR P35968 4/20 0.37
FLT1 P17948 3/20 0.37
FLT3 P36888 3/20 0.37
NPC1 O15118 2/20 0.37
RAB9A P51151 2/20 0.37
PPARG P37231 1/20 0.36
PPARA Q07869 1/20 0.36
RET P07949 1/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
AURKA O14965 1/20 0.36
TNIK Q9UKE5 1/20 0.36
HTT P42858 1/20 0.36
PARP1 P09874 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22356641 0.73 ADORA3 (0.46) NPY5RNPC1RAB9ATNIK
SCHEMBL28378015 0.69 ENPP2 (0.46) ALDH1A1ENPP2KDRFLT1FLT3
SCHEMBL22356644 0.69 RXFP1 (0.43) NPY5RKDRNPC1RAB9ARET
SCHEMBL28378012 0.67 USP30 (0.46) ALDH1A1MEN1KMT2A
SCHEMBL26068711 0.65 ALDH1A1 (0.66) L3MBTL1ALDH1A1MAPK1NPC1RAB9A
SCHEMBL5162705 0.63 ALDH1A1 (0.58) L3MBTL1ALDH1A1MAPK1MEN1KMT2A
SCHEMBL6687005 0.63 ALDH1A1 (0.68) L3MBTL1ALDH1A1MAPK1KMT2A
SCHEMBL15888187 0.63 ALDH1A1 (0.54) L3MBTL1ALDH1A1MAPK1ENPP2PPARG
SCHEMBL15647513 0.63 MGLL (0.67) L3MBTL1ALDH1A1MAPK1ENPP2NPC1
SCHEMBL27499661 0.62 ALDH1A1 (0.92) L3MBTL1ALDH1A1MAPK1ENPP2KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200262827-A1 AROMATIC DERIVATIVE, PREPARATION METHOD FOR SAME, AND MEDICAL APPLICATIONS THEREOF BIOARDIS LLC (US) 2020-08-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200262827-A1 AROMATIC DERIVATIVE, PREPARATION METHOD FOR SAME, AND MEDICAL APPLICATIONS THEREOF FGFR4, FGFR1, FGFR3 NPY5R 1264/4885L3MBTL1 4857/4885ALDH1A1 1130/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.